LMAT LeMaitre Vascular, Inc.

NASDAQ
$80.89

LeMaitre Vascular, Inc. (LMAT) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is $0.75 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.1% since its last earnings release on November 4, 2026.

LeMaitre Vascular Missed Expectations, Guides Below Estimates
Wednesday, November 4, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.75
Rev est $71.42M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $82.50

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About LeMaitre Vascular, Inc.

LeMaitre Vascular Inc provides medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.